Skip to main content
. 2017 Feb 17;7:42979. doi: 10.1038/srep42979

Figure 3. The effect of chemotherapy on survival in patients with NSCLC and BM.

Figure 3

(A,D) Chemotherapy plus bisphosphonates showed similar PFS and OS than chemotherapy alone in patients with NSCLC; (B,E) Chemotherapy plus bisphosphonates showed no superior PFS and OS than chemotherapy alone in NSCLC patients with EGFR mutations and BM; (C,F) Chemotherapy plus bisphosphonates showed no superior PFS and OS than chemotherapy alone in NSCLC patients with EGFR wild type and BM.